These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8283360)

  • 1. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy.
    Ferrara TB; Hoekstra RE; Couser RJ; Gaziano EP; Calvin SE; Payne NR; Fangman JJ
    J Pediatr; 1994 Jan; 124(1):119-24. PubMed ID: 8283360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of surfactant therapy on outcome of extremely premature infants.
    Hoekstra RE; Ferrara TB; Payne NR
    Eur J Pediatr; 1994; 153(9 Suppl 2):S12-6. PubMed ID: 7957437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant therapy in extremely premature infants.
    Merritt TA
    J Pediatr; 1994 Jul; 125(1):172-3; author reply 173-4. PubMed ID: 8021775
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
    Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
    J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of infants 23-26 weeks' gestation pre and post surfactant.
    Jacobs SE; O'Brien K; Inwood S; Kelly EN; Whyte HE
    Acta Paediatr; 2000 Aug; 89(8):959-65. PubMed ID: 10976839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant therapy in extremely premature infants.
    Bose C; McCaffrey M
    J Pediatr; 1994 Jul; 125(1):173; author reply 173-4. PubMed ID: 8021776
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?
    Horbar JD; Carpenter JH; Buzas J; Soll RF; Suresh G; Bracken MB; Leviton LC; Plsek PE; Sinclair JC;
    Pediatrics; 2004 Jun; 113(6):1593-602. PubMed ID: 15173479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for survival for out-born infants born between 23 and 24 weeks of gestation in the post-surfactant era: fourteen years' experience in a single neonatal care unit, 1987-2000.
    Hosono S; Ohno T; Kimoto H; Shimizu M; Takahashi S; Harada K
    Pediatr Int; 2008 Oct; 50(5):640-3. PubMed ID: 19261111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
    Sell M; Cotton R; Hirata T; Guthrie R; LeBlanc M; Mammel M; Long W
    J Pediatr; 1995 May; 126(5 Pt 2):S20-5. PubMed ID: 7745507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal corticosteroid and early surfactant therapy in infants born at < or = 30 weeks gestation].
    Valls i Soler A; Páramo Andrés S; Fernández-Ruanova B;
    An Pediatr (Barc); 2004 Aug; 61(2):118-23. PubMed ID: 15274875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants.
    Lang MJ; Hall RT; Reddy NS; Kurth CG; Merritt TA
    J Pediatr; 1990 Feb; 116(2):295-300. PubMed ID: 2405141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.